St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project has identified the genetic basis of three pediatric melanoma subtypes; findings could lead to better diagnosis and treatment
MRV Research
Novel Risk Score Could Identify Melanoma Risk
A novel risk score may be able to identify patients who are at risk for developing melanoma, according to a recent study published online ahead of print in Cancer Epidemiology, Biomarkers & Prevention
Myriad Genetics (MYGN) Reports Publication of Positive myPath Melanoma Data
Myriad Genetics announced the Journal of Cutaneous Pathology published data from a pivotal clinical validation study that showed the myPath Melanoma test is highly effective at differentiating benign skin moles from malignant melanoma with greater than 90 percent diagnostic accuracy.1 Melanoma is the most dangerous type of skin cancer and more than 76,000 new cases of melanoma are diagnosed each year in the United States.
National Cancer Institute grant enables Rutgers CINJ investigators to explore melanoma metastasis
The mechanism by which small cellular vesicles promote melanoma metastasis (spread of disease), will be further explored by investigators at Rutgers Cancer Institute of New Jersey and the Ernest Mario School of Pharmacy at Rutgers University.A recently awarded $200,000 grant (R21CA185835) from the National Cancer Institute to researchers Suzie Chen, Ph.D., and James S. Goydos, M.D., FACS, will support the work.